Key Takeaways
- • Swiss M&A deal value reached approximately $44 billion in the first eight months of 2026, representing a 20% year-on-year increase and slightly above the country's eight-year average, according to Boston Consulting Group data cited by Bloomberg.
- • Private equity captured only $8 billion of Swiss transactions during the period, marking the second-lowest annualized level recorded over the past eight years, reflecting a significant loss of market share to strategic corporate buyers.
- • The largest Swiss transactions have been corporate-led, including Zurich Insurance Group's $10.9 billion acquisition of UK specialist insurer Beazley and ABB's $5.6 billion purchase of automation company Rotork, demonstrating cash-rich corporates' competitive advantage.
- • PE activity included CVC Capital Partners' $2.6 billion acquisition of DSM-Firmenich's animal nutrition and health business and Lone Star's deal for part of chemicals group Lonza, though these represent smaller deal sizes relative to strategic acquisitions.
- • BCG partner Jeremy Merz attributed PE's declining share to increased strategic buyer appetite and pressure on private equity managers to realize existing investments before raising and deploying fresh capital, noting this phenomenon is specific to Switzerland rather than reflective of global PE trends.
Summary
Swiss M&A activity has recovered substantially in 2026, but private equity firms have lost significant ground to strategically-motivated corporate buyers seeking to deploy strengthened balance sheets and improved earnings. According to Bloomberg's reporting of Boston Consulting Group analysis, Swiss deal value reached approximately $44 billion in the first eight months of the year, up roughly 20% year-on-year and slightly exceeding the country's eight-year historical average. This recovery reflects broader global M&A momentum, with companies navigating geopolitical and energy-market uncertainty through acquisitive expansion.
However, the composition of dealmaking has shifted materially against PE sponsors. Private equity accounted for only $8 billion of Swiss transactions during the January-August period, representing the second-lowest annualized level in the past eight years. The largest transactions have been dominated by strategic buyers with substantial liquidity: Zurich Insurance Group's $10.9 billion acquisition of UK-based specialist insurer Beazley and ABB's $5.6 billion purchase of automation company Rotork exemplify this corporate-led trend. These headline deals dwarf the PE contribution, which included CVC Capital Partners' $2.6 billion acquisition of DSM-Firmenich's animal nutrition and health business and Lone Star's partial acquisition within chemicals group Lonza.
Jeremy Merz, a partner and managing director at BCG, attributed the PE sector's compressed market share to dual pressures: increased strategic buyer appetite for acquisitions and competitive constraints on PE managers who face obligations to realize existing portfolio holdings before returning to market to raise and deploy new capital. Notably, Merz characterized this phenomenon as specific to Switzerland, emphasizing that private equity has maintained a comparatively stronger proportion of deal activity in other global markets. The divergence suggests Switzerland's particular dynamics—potentially including its concentrated base of cash-rich multinational corporates and the maturity of its domestic PE base—are driving the market shift rather than a universal contraction in sponsor-led dealmaking.
However, the composition of dealmaking has shifted materially against PE sponsors. Private equity accounted for only $8 billion of Swiss transactions during the January-August period, representing the second-lowest annualized level in the past eight years. The largest transactions have been dominated by strategic buyers with substantial liquidity: Zurich Insurance Group's $10.9 billion acquisition of UK-based specialist insurer Beazley and ABB's $5.6 billion purchase of automation company Rotork exemplify this corporate-led trend. These headline deals dwarf the PE contribution, which included CVC Capital Partners' $2.6 billion acquisition of DSM-Firmenich's animal nutrition and health business and Lone Star's partial acquisition within chemicals group Lonza.
Jeremy Merz, a partner and managing director at BCG, attributed the PE sector's compressed market share to dual pressures: increased strategic buyer appetite for acquisitions and competitive constraints on PE managers who face obligations to realize existing portfolio holdings before returning to market to raise and deploy new capital. Notably, Merz characterized this phenomenon as specific to Switzerland, emphasizing that private equity has maintained a comparatively stronger proportion of deal activity in other global markets. The divergence suggests Switzerland's particular dynamics—potentially including its concentrated base of cash-rich multinational corporates and the maturity of its domestic PE base—are driving the market shift rather than a universal contraction in sponsor-led dealmaking.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.